ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly net cash used for investing activities ($M) ($M)
Annual figures from Eli Lilly's filings and investor materials
Latest, FY2025
-10,972
Period ended Dec 31, 2025
Change on a year earlier
+18.0%
-9,302 in FY2024
History
19 years
Since FY2007
Sources
14
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Net cash used for investing activities ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | -10,972 | +18.0% | Form 10-K (filed 2026-02-12) ↗ |
| FY2024 | Dec 31, 2024 | -9,302 | +30.0% | Form 10-K (filed 2026-02-12) ↗ |
| FY2023 | Dec 31, 2023 | -7,153 | +90.1% | Form 10-K (filed 2026-02-12) ↗ |
| FY2022 | Dec 31, 2022 | -3,763 | +31.2% | Form 10-K (filed 2024-02-21) ↗ |
| FY2021 | Dec 31, 2021 | -2,868 | +26.9% | Form 10-K (filed 2024-02-21) ↗ |
| FY2020 | Dec 31, 2020 | -2,259 | -72.1% | Form 10-K (filed 2021-02-17) ↗ |
| FY2019 | Dec 31, 2019 | -8,083 | -524.1% | Form 10-K (filed 2020-02-19) ↗ |
| FY2018 | Dec 31, 2018 | 1,906 | -150.4% | Form 10-K (filed 2019-02-19) ↗ |
| FY2017 | Dec 31, 2017 | -3,784 | +20.5% | Form 10-K (filed 2018-02-20) ↗ |
| FY2016 | Dec 31, 2016 | -3,139 | -11,813.1% | Form 10-K (filed 2017-02-21) ↗ |
| FY2015 | Dec 31, 2015 | 26.8 | -100.7% | Form 10-K (filed 2016-02-19) ↗ |
| FY2014 | Dec 31, 2014 | -3,909 | +88.6% | Form 10-K (filed 2015-02-19) ↗ |
| FY2013 | Dec 31, 2013 | -2,073 | -26.8% | Form 10-K (filed 2014-02-19) ↗ |
| FY2012 | Dec 31, 2012 | -2,833 | -41.3% | Form 10-K (filed 2013-02-21) ↗ |
| FY2011 | Dec 31, 2011 | -4,824 | +52.7% | Form 10-K (filed 2012-02-24) ↗ |
| FY2010 | Dec 31, 2010 | -3,160 | -2,312.7% | Form 10-K (filed 2011-02-22) ↗ |
| FY2009 | Dec 31, 2009 | 143 | -102.0% | Form 10-K (filed 2010-02-22) ↗ |
| FY2008 | Dec 31, 2008 | -7,269 | +67.9% | Form 10-K (filed 2010-02-22) ↗ |
| FY2007 | Dec 31, 2007 | -4,328 | – | Form 10-K (filed 2010-02-22) ↗ |
Breakdown
What makes up net cash used for investing activities ($m)
Cite this data
StockData. (2026). Eli Lilly Net cash used for investing activities ($M) ($M), annual FY2007–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/fin_icf
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.